TGFB1 and infection: 30μg soluble betaglycan administered twice a week by intraperitoneal route from 30 days post infection, with/without 500μg niflumic acid administered twice a day by intragastric cannulation, or pan-specific TGF-β antibodies. Mice euthanased at 15, 30, 45, and 60 days